Recent advances in immunotherapy for non-small-cell lung cancer

Despite of recent development in the field of molecular targeted therapies, lung cancer is a leading cause of cancer death in the world. Remarkable progress has been made recently in immunotherapy for patients with non-small-cell lung cancer (NSCLC), with several modalities, concepts, and treatment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Suzuki, Hiroyuki, Owada, Yuki, Watanabe, Yuzuru, Inoue, Takuya, Fukuharav, Mitsuro, Yamaura, Takumi, Mutoh, Satoshi, Okabe, Naoyuki, Yaginuma, Hiroshi, Hasegawa, Takeo, Yonechi, Atsushi, Ohsugi, Jun, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Gotoh, Mitsukazu
Formato: Artigo
Lenguaje:Inglês
Publicado: Landes Bioscience 2014
Materias:
Commentary
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185902/
https://ncbi.nlm.nih.gov/pubmed/24196313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.26919
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares